CClinicalTrials.gg
Status unknownNCT04098380E-STITCHUpdated Sep 23, 2019

Small Versus Large Bite Closure of Emergency Midline Laparotomy

An interventional study of Small Bite and Larger bite in Hernia, Ventral, sponsored by Mansoura University. Status unknown at 1 site in Egypt. Open to participants aged 16 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-09-23.

Sponsored by Mansoura University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
16 Years to 70 Years
Sex
All
01

Study summary

In daily practice, midline laparotomy is an incision frequently performed by surgeons to achieve a rapid and wide access to the abdomen. However, incisional hernia stands as the most common complication following this type of incision, with an incidence reaching up to 20% and even higher in the case of emergency laparotomy.

A recent randomized controlled trial compared small bite sutures and large bite closure of elective midline laparotomy and reported a significant decrease of incisional hernia rate from 18% to 5.6% in favor of small-bite technique. These promising results were subsequently confirmed in a wide-scale multicenter double-blinded randomized trial, the STITCH study.

The investigators will conduct this randomized controlled trial to compare the small tissue bite (SB) technique and the large bite (LB) technique for closure of emergency midline laparotomy. The main outcome of the study will be the incidence of incisional hernia within one year after surgery.

02

Conditions studied

  • Hernia, Ventral

Browse trials for

03

In context

Hernia, Ventral

254 studies on the registry are indexed under Hernia, Ventral; 46 are open to participants now.

This study's planned enrollment of 160 is above the median of 95 across 159 interventional studies indexed under Hernia, Ventral.

Browse Hernia, Ventral studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients of both sexes aging less than 70 years old

Exclusion criteria

Exclusion Criteria:

  • All procedures which will be performed on elective basis will be excluded
  • patients who are pregnant.
  • Patients on systemic steroid or chemotherapy
  • patients with incisional hernia or fascial defect; and/or relaparotomy within 30-days of another surgical intervention.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Active comparator
    Small bite

    The needle bites will be applied with a bite width of 5 mm and inter-suture spacing of 5 mm

    Procedure: Small Bite

  • Active comparator
    Large bite

    The needle bites will be applied with a width of 10 mm and inter-suture spacing of 10 mm

    Procedure: Larger bite

Interventions

  • ProcedureSmall Bite

    the bites will be applied with a bite width of 5 mm and inter-suture spacing of 5 mm

  • ProcedureLarger bite

    the bites will be applied with a width of 10 mm and inter-suture spacing of 10 mm

06

What researchers measure

Primary outcomes

  1. Incidence of incisional hernia

    Diagnosis of incisional hernia within 12 months after surgery by clinical examination or by ultrasound

    Time frame: 12 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Mansoura university hospital
    Mansourah, Dakahlia 35516, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04098380
Lead sponsor
Mansoura University
Responsible party
Sameh Emile (Lecturer of surgery, Mansoura University) — Principal investigator
First posted
Sep 23, 2019
Start date
Sep 21, 2019 (estimated)
Primary completion
Dec 30, 2020 (estimated)
Completion
Dec 30, 2021 (estimated)
Last update
Sep 23, 2019

Study contacts

Sameh Emile, M.D.
Contact
sameh200@hotmail.com
201006767150
Sameh Emile, M.D.
principal investigator · Mansoura University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion